These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [The primary proliferative processes of the hemopoietic system]. Introzzi P Minerva Med; 1969 Sep; 60(74):3399-450. PubMed ID: 4981171 [No Abstract] [Full Text] [Related]
6. [Results of cytostatic therapy of malignant hemoblastoses]. Stacher A Wien Z Inn Med; 1966 Jan; 47(1):1-16. PubMed ID: 4962311 [No Abstract] [Full Text] [Related]
7. Critical study of the mononuclear leukocyte morphology based on scanning electron microscopy in normal subjects and in patients with lymphoid or monocytoid proliferative disorders. Comparison with the T, B or null cell membrane phenotypes. Dantchev D; Belpomme D Biomedicine; 1977 May; 26(3):202-22. PubMed ID: 407952 [No Abstract] [Full Text] [Related]
8. THE RELATIONSHIP OF CHRONIC ULCERATION OF THE ILEOCECAL JUNCTION TO THE DEVELOPMENT OF RETICULOENDOTHELIAL TUMORS IN C3H MICE. PILGRIM HI Cancer Res; 1965 Jan; 25():53-65. PubMed ID: 14254994 [No Abstract] [Full Text] [Related]
9. [SURVIVAL TIME AND ABILITY TO WORK IN HEMOBLASTOSES TREATED BY CHEMOTHERAPY]. PRAETORIUS E Dtsch Arch Klin Med; 1963 Dec; 209():192-218. PubMed ID: 14126764 [No Abstract] [Full Text] [Related]
11. [Diffuse lymphatic hyperplasia, lymphoma and pseudolymphoma of the gastrointestinal system]. Rösch W; Fuchs H Dtsch Med Wochenschr; 1972 Jun; 97(22):878-81. PubMed ID: 4624285 [No Abstract] [Full Text] [Related]
12. [New viewpoints for indication for radiologic treatment in leukoses and retikuloses]. Musshoff K Strahlentherapie; 1968 Jun; 135(6):641-55. PubMed ID: 4878792 [No Abstract] [Full Text] [Related]
13. [THE EFFECT OF CHEMOTHERAPY ON THE PROGNOSIS OF HEMOBLASTOSES]. PRAETORIUS E; GERHARTZ H Krebsforsch Krebsbekampf; 1964; 30():106-11. PubMed ID: 14283693 [No Abstract] [Full Text] [Related]
14. [The morpho-functional test of blood lymphocytes in proliferative blood diseases. Case reports]. D'Arrigo S; Lanza C; Lazzaro C Riv Patol Clin Sper; 1968; 9(1):3-18. PubMed ID: 4973516 [No Abstract] [Full Text] [Related]
15. [STUDY OF THE CLINICAL FORMS OF MALIGNANT RETICULOSIS]. PETRESCU M; OLARU C; SIGHETEA E; GROZEA P; GEIB R; GOCIU M Stud Cercet Med Interna; 1963; 123():781-93. PubMed ID: 14107487 [No Abstract] [Full Text] [Related]
16. [RESULTS OF TREATMENT WITH DOPANE IN SOME TUMORS OF THE HEMOPOIETIC SYSTEM]. MUNTEANU N; BUTOIANU E; TAIGAR S Med Interna (Bucur); 1963 Dec; 15():1477-80. PubMed ID: 14101031 [No Abstract] [Full Text] [Related]
17. [THERAPY OF HEMOLYMPHOPATHIES WITH PREDNISONE AT HIGH DOSES]. DEBLASIIS M Arch Patol Clin Med; 1964 Mar; 40():347-73. PubMed ID: 14161375 [No Abstract] [Full Text] [Related]
18. [Clinical hematological aspects of rare cells in leukocyte concentrates]. Klima R Krebsarzt; 1967; 22(1):3-9. PubMed ID: 4873329 [No Abstract] [Full Text] [Related]